Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease.
Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus MA, Marroquin OC, Rao SV, Noveck H, Passano E, Hardison RM, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO. Carson JL, et al. Among authors: marroquin oc. Am Heart J. 2013 Jun;165(6):964-971.e1. doi: 10.1016/j.ahj.2013.03.001. Epub 2013 Apr 8. Am Heart J. 2013. PMID: 23708168 Free PMC article. Clinical Trial.
Response to Dr Sandar et al.
Carson JL, Brooks MM, Abbott JD, Kelsey SF, Triulzi DJ, Menegus MA, Marroquin OC, Rao SV, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO. Carson JL, et al. Among authors: marroquin oc. Am Heart J. 2013 Oct;166(4):e27-8. doi: 10.1016/j.ahj.2013.07.022. Epub 2013 Aug 29. Am Heart J. 2013. PMID: 24093866 No abstract available.
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Am Heart J. 2008 Sep;156(3):528-536, 536.e1-5. doi: 10.1016/j.ahj.2008.05.015. Epub 2008 Jul 31. Am Heart J. 2008. PMID: 18760137 Free PMC article. Clinical Trial.
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.
Holper EM, Abbott JD, Mulukutla S, Vlachos H, Selzer F, McGuire D, Faxon DP, Laskey W, Srinivas VS, Marroquin OC, Jacobs AK. Holper EM, et al. Among authors: marroquin oc. Am Heart J. 2011 Feb;161(2):397-403.e1. doi: 10.1016/j.ahj.2010.11.004. Am Heart J. 2011. PMID: 21315225
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry).
Green SM, Selzer F, Mulukutla SR, Tadajweski EJ, Green JA, Wilensky RL, Laskey WK, Cohen HA, Rao SV, Weisbord SD, Lee JS, Reis SE, Kip KE, Kelsey SF, Williams DO, Marroquin OC. Green SM, et al. Among authors: marroquin oc. Am J Cardiol. 2011 Dec 1;108(11):1658-64. doi: 10.1016/j.amjcard.2011.07.029. Epub 2011 Sep 3. Am J Cardiol. 2011. PMID: 21890077 Free PMC article. Clinical Trial.
Incidence and predictors of 30-day hospital readmission rate following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
Ricciardi MJ, Selzer F, Marroquin OC, Holper EM, Venkitachalam L, Williams DO, Kelsey SF, Laskey WK. Ricciardi MJ, et al. Among authors: marroquin oc. Am J Cardiol. 2012 Nov 15;110(10):1389-96. doi: 10.1016/j.amjcard.2012.07.002. Epub 2012 Jul 30. Am J Cardiol. 2012. PMID: 22853982 Free PMC article.
Five-year follow-up of patients treated for coronary artery disease in the face of an increasing burden of co-morbidity and disease complexity (from the NHLBI Dynamic Registry).
Bortnick AE, Epps KC, Selzer F, Anwaruddin S, Marroquin OC, Srinivas V, Holper EM, Wilensky RL. Bortnick AE, et al. Among authors: marroquin oc. Am J Cardiol. 2014 Feb 15;113(4):573-9. doi: 10.1016/j.amjcard.2013.10.039. Epub 2013 Nov 28. Am J Cardiol. 2014. PMID: 24388624 Free PMC article.
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
BARI 2D Study Group; Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. BARI 2D Study Group, et al. N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7. N Engl J Med. 2009. PMID: 19502645 Free PMC article. Clinical Trial.
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.
Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO. Mulukutla SR, et al. Among authors: marroquin oc. Am J Cardiol. 2013 Feb 15;111(4):486-92. doi: 10.1016/j.amjcard.2012.10.030. Epub 2012 Dec 1. Am J Cardiol. 2013. PMID: 23211356 Free PMC article. Clinical Trial.
129 results